News From Industry Sources
Polyanalgesic Consensus Panel's new treatment guidelines via intraspinal infusion for severe chronic pain
October 31, 2007
The Polyanalgesic Consensus Panel revised the guidelines used to determine treatment via intraspinal infusion for patients suffering from severe chronic pain. The updated algorithm includes PRIALT as a first-line alternative for intraspinal infusion to the opioids morphine and hydromorphone. Story
Voltaren Gel receives US regulatory approval as the first approved topical prescription treatment for pain associated with osteoarthritis
October 22, 2007
Voltaren Gel is the First US approval for a prescription NSAID (non-steroidal anti-
inflammatory drug) treatment that can be applied directly to site of osteoarthritis pain and the only prescription topical medication proven to significantly reduce osteoarthritis pain in both the knees and the joints of the hands Story
Forget the old stereotypes - new survey reveals that baby boomers are feeling more young and active than ever!
October 18, 2007
More than two out of three boomers (67 percent) admit they suffer from muscle or joint pain, most of which (63 percent) occurs at least once a week. While more than 90 percent believe chronic muscle and joint pain is treatable, more than half (52 percent) prefer to seek out homeopathic remedies or natural solutions rather than medication. Story
Review of probiotic trial research finds only Bifantis able to claim efficacy versus placebo for IBS symptoms
October 15, 2007
A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis(R), Bifidobacterium infantis 35624, the sole ingredient in Align(R) (manufactured by Procter & Gamble), is the only probiotic currently able to demonstrate significant improvement in IBS symptoms. Story
|
